Camlin Fine Sciences Ltd

CAMLINFINE

Company Profile

  • Business description

    Camlin Fine Sciences Ltd is engaged in the research, development, manufacturing, and marketing of specialty chemicals, ingredients, and additive blends. Its broad product portfolio includes Shelf-Life Solutions, Aroma Ingredients, Performance Chemicals, and Health & Wellness. The Company operates through one reporting business segment, Specialty Chemicals. Its products include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), Tert Butylcatechol (TBC), Guaiacol, Veratrole, Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus. It serves Food & Beverages, Petfood and Rendering, Animal Nutrition, Petrochemicals, Nutrition & Health, Biofuel, Flavours & Fragrances, and other industries, and generates maximum revenue from the domestic market.

  • Contact

    CST Road, Kalina
    Floor 2 to 5, In GS Point
    Santacruz East
    MumbaiMH400 098
    IND

    T: +91 2267001000

    https://www.camlinfs.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    31 March 2027

    Employees

    1,439

Stocks News & Analysis

stocks

CSL’s latest result suggests the worst may be over

Relief replaces disappointment but can growth return?
stocks

ASX listed pharma boosted by weight loss drugs

GLP-1 momentum drives earnings for narrow moat share.
stocks

Nvidia earns upgrade as AI buildouts accelerate

Demand for AI infrastructure shows no signs of slowing.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,271.406.300.07%
CAC 408,416.9715.790.19%
DAX 4026,407.25162.74-0.61%
Dow JONES (US)53,559.999.45-0.02%
FTSE 10010,824.2631.720.29%
HKSE25,566.9917.80-0.07%
NASDAQ26,402.42138.93-0.52%
Nikkei 22566,311.9393.63-0.14%
NZX 50 Index13,917.30149.121.08%
S&P 5007,711.7619.23-0.25%
S&P/ASX 2009,076.0010.400.11%
SSE Composite Index3,986.3034.120.86%

Market Movers